Delivery Order SPE2DB20D2014-SPE2DB25FB72L

Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,197.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order (SPE2DB25D3017|SPE2DB25FVHTB) for the supply of Lantus Solostar 100 unit/ml 3ml, a diabetes medication. The contract has an ultimate completion date of April 16, 2025 and is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,734.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of February 9, 2024, is for the delivery of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $1,436.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Lantus Solostar 100 unit/ml 3ml, a specialty medication used for diabetes management. The contract has an ultimate completion date of May 16, 2024 and is a firm fixed-price arrangement. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.60 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a specialty medication used for diabetes management. The contract has an ultimate completion date of March 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,406.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for DLA Troop Support Medical to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,545.06, is a delivery order contract to supply 4,567,956,668 units of Lantus Solostar 100 Unit/ML 3ML, a diabetes medication. The contract has an ultimate completion date of April 18, 2025 and is a firm fixed-price agreement. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,988.47 fixed-price contract is for the supply of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The award has an ultimate completion date of August 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,409.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Lantus Solostar 100 unit/ml 3ml, a critical diabetes medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is a delivery order under Amerisourcebergen's Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,557.73, is a delivery order for Lantus Solostar 100 unit/mL 3mL, a specialty medication used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $2,051.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 and running through November 2026. The contract covers the procurement of Lantus Solostar 100 unit/mL 3mL, a critical pharmaceutical product used for the management...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB72L
    Delivery Order

This federal contract award, valued at $1,098.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a diabetes medication.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

The contract award is not designated as a set-aside, indicating open competition. Amerisourcebergen Drug Corp, as the prime contractor, will be responsible for fulfilling the delivery order. The ultimate completion date for this contract is April 24, 2025.

Generated 7/23/25, 9:42 AM